Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,177
archived clinical trials in
Orthopedic

Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
La Jolla, CA
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
La Jolla, CA
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Gainesville, FL
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Gainesville, FL
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Miami Lakes, FL
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Rochester, MN
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Rochester, MN
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Spartanburg, SC
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Orlando, FL
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Gainesville, GA
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Gainesville, GA
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Madison, WI
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Madison, WI
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Farmington, CT
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Farmington, CT
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
High Point, NC
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
High Point, NC
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Mesquite, TX
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Mesquite, TX
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
San Antonio, TX
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Adelaide,
Dose Range Finding Study of Bimagrumab in Sarcopenia
A 28 Week, Randomized, Double-blind, Placebo-controlled, Two-part, Multi-center, Parallel Group Dose Range Finding Study to Assess the Effect of Monthly Doses of Bimagrumab 70, 210, and 700 mg on Skeletal Muscle Strength and Function in Older Adults With Sarcopenia (InvestiGAIT)
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Adelaide,
Click here to add this to my saved trials
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated:  12/31/1969
R Adams Cowley Shock Trauma Center
mi
from
Baltimore, MD
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated: 12/31/1969
R Adams Cowley Shock Trauma Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated:  12/31/1969
Jacobi Medical Center
mi
from
New York, NY
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated: 12/31/1969
Jacobi Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated:  12/31/1969
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated: 12/31/1969
UT Health Science Center - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated:  12/31/1969
Helsinki University Hospital
mi
from
Helsinki,
A Multicenter RCT to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
A Multicenter Randomized Controlled Clinical Investigation to Investigate the Treatment of Double (Bilateral) Mandibular Fractures
Status: Enrolling
Updated: 12/31/1969
Helsinki University Hospital
mi
from
Helsinki,
Click here to add this to my saved trials
Clinical Trial of a Serious Game for Individuals With SCI/D
Evaluating the Effectiveness of a Serious Game to Enhance Self-Management Skills Among Adolescents and Young Adults With Spinal Cord Dysfunction
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Clinical Trial of a Serious Game for Individuals With SCI/D
Evaluating the Effectiveness of a Serious Game to Enhance Self-Management Skills Among Adolescents and Young Adults With Spinal Cord Dysfunction
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection in a Double-Blinded Randomized Controlled Study (PRPLE)
Status: Enrolling
Updated:  12/31/1969
Kaiser Permanente
mi
from
Modesto, CA
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection
Multiple Platelet-Rich Plasma Lateral Epidondylitis Injections Versus a Single Platelet-Rich Plasma Injection in a Double-Blinded Randomized Controlled Study (PRPLE)
Status: Enrolling
Updated: 12/31/1969
Kaiser Permanente
mi
from
Modesto, CA
Click here to add this to my saved trials
Locked Versus Unlocked Set Screws in Intramedullary Fixation of Intertrochanteric Fractures
Does Static Locking of Set Screws in Intramedullary Fixation of Intertrochanteric Fractures Prevent Shortening of Intertrochanteric Hip Fractures?
Status: Enrolling
Updated:  12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Locked Versus Unlocked Set Screws in Intramedullary Fixation of Intertrochanteric Fractures
Does Static Locking of Set Screws in Intramedullary Fixation of Intertrochanteric Fractures Prevent Shortening of Intertrochanteric Hip Fractures?
Status: Enrolling
Updated: 12/31/1969
Bassett Healthcare Network
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Mattel Children's Hospital and David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Mattel Children's Hospital and David Geffen School of Medicine at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Colorado
mi
from
Aurora, CO
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Ohio State University Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
The Safety of ahSC in Chronic SCI With Rehabilitation
The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Miami, FL
The Safety of ahSC in Chronic SCI With Rehabilitation
The Safety of Autologous Human Schwann Cells (ahSC) in Subjects With Chronic Spinal Cord Injury (SCI) Receiving Rehabilitation
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Rancho Los Amigos/USC
mi
from
Los Angeles, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Rancho Los Amigos/USC
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Shepherd Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Indiana University
mi
from
Indianapolis, IN
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Washington University
mi
from
Saint Louis, MO
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Thomas Jefferson University/Magee Rehabilitation
mi
from
Philadelphia, PA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University/Magee Rehabilitation
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated:  12/31/1969
Stanford University/Santa Clara Valley Medical Center
mi
from
San Jose, CA
Dose Escalation Study of AST-OPC1 in Spinal Cord Injury
A Phase 1/2a Dose Escalation Study of AST-OPC1 in Subjects With Subacute Cervical Spinal Cord Injury
Status: Enrolling
Updated: 12/31/1969
Stanford University/Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Stanford School of Medicine
mi
from
Redwood City, CA
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Stanford School of Medicine
mi
from
Redwood City, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Midwest Orthopaedics at Rush
mi
from
Chicago, IL
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Midwest Orthopaedics at Rush
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
MedStar Franklin Square Medical Center
mi
from
Baltimore, MD
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
MedStar Franklin Square Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Hackensack University Medical Center
mi
from
Hackensack, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Duke University School of Medicine
mi
from
Durham, NC
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Duke University School of Medicine
mi
from
Durham, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
The Ohio State University, Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated:  12/31/1969
University Orthopedics Inc.
mi
from
Providence, RI
Safety and Efficacy Study of Treatment of Pathological Fractures in Humerus
A Prospective, Multi-Center Study of the IlluminOss® Photodynamic Bone Stabilization System for the Treatment of Impending and Actual Pathological Fractures in the Humerus From Metastatic Bone Disease
Status: Enrolling
Updated: 12/31/1969
University Orthopedics Inc.
mi
from
Providence, RI
Click here to add this to my saved trials